Neoadjuvant Chemoradiation With Paclitaxel/Carboplatin for Selected Stage III Non–Small-Cell Lung Cancer: Long-Term Results of a Trimodality Phase II Protocol-Reference-Cited by-同舟云学术

Neoadjuvant Chemoradiation With Paclitaxel/Carboplatin for Selected Stage III Non–Small-Cell Lung Cancer: Long-Term Results of a Trimodality Phase II Protocol

Published:2010-04 Issue:5 Volume:76 Page:1376-1381
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Hehr Thomas,Friedel Godehard,Steger Volker,Spengler Werner,Eschmann Susanne M.,Bamberg Michael,Budach Wilfried

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference38 articles.

1. Non-small cell lung cancer;Ginsberg,1997

2. Revisions in the International System for Staging Lung Cancer;Mountain;Chest,1997

3. Survival of patients with resected N2 non-small-cell lung cancer: Evidence for a subclassification an implications;Andre;J Clin Oncol,2000

4. Induction therapy for locally advanced non-small-cell lung cancer;Albain,2000

5. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group;Perez;Cancer,1987

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemoradiation Therapy Followed by Surgery in the Treatment of Locoregionally Advanced Non–Small Cell Lung Cancer;The Thoracic and Cardiovascular Surgeon;2017-10-09

2. Positron Emission Tomography;Murray and Nadel's Textbook of Respiratory Medicine;2016

3. Trimodal therapy for stage III-N2 non-small-cell lung carcinoma: a single center retrospective analysis;BMC Cancer;2014-08-07

4. Reply to K. Devisetty et al;Journal of Clinical Oncology;2013-08-10

5. Neoadjuvant chemoradiotherapy for stage III (N2/3) non-small-cell lung cancer: a review of prospective studies;Lung Cancer Management;2013-02